MARKET

NVNO

NVNO

Envveno Medical Corporation
NASDAQ
11.04
+0.28
+2.60%
Opening 13:01 07/16 EDT
OPEN
10.79
PREV CLOSE
10.76
HIGH
11.04
LOW
10.56
VOLUME
5.36K
TURNOVER
--
52 WEEK HIGH
196.70
52 WEEK LOW
8.67
MARKET CAP
7.37M
P/E (TTM)
-0.3523
1D
5D
1M
3M
1Y
5Y
1D
enVVeno Medical highlights newly issued U.S. patent
TipRanks · 1d ago
enVVeno Medical wins first US patent covering enVVe system
PUBT · 1d ago
enVVeno Medical Updates Investors With New Presentation
TipRanks · 1d ago
Weekly Report: what happened at NVNO last week (0706-0710)?
Weekly Report · 3d ago
enVVeno Medical secures U.S. patent for enVVe system
TipRanks · 07/07 12:45
EnVVeno Medical Issued U.S. Patent For Its Intellectual Property Portfolio Supporting Its enVVe Transcatheter Replacement Venous Valve System To Treat Venous Disease
Benzinga · 07/07 12:30
enVVeno Medical wins U.S. patent covering enVVe transcatheter venous valve system
PUBT · 07/07 12:29
enVVeno Medical upgraded to Buy from Neutral at Ladenburg
TipRanks · 07/06 15:05
More
About NVNO
enVVeno Medical Corporation is a late clinical-stage medical device company. The Company is focused on the advancement of bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of venous disease. The Company is developing surgical and non-surgical replacement venous valves for patients suffering from severe chronic venous insufficiency (CVI) of the deep venous system of the leg. The Company’s lead product is the VenoValve, which is a surgical replacement venous valve that is being evaluated in a U.S. pivotal study. The VenoValve is implanted into the femoral vein of the patient in an open surgical procedure via a 5-to-6-inch incision in the upper thigh. The Company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the VenoValve and enVVe are designed to act as one-way valves, to help assist in propelling blood up the veins of the leg, and back to the heart and lungs.

Webull offers enVVeno Medical Corp stock information, including NASDAQ: NVNO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NVNO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NVNO stock methods without spending real money on the virtual paper trading platform.